APPOINTS TIM LEDWICK AS CHIEF FINANCIAL OFFICER AND CHRISTOPHER DEVALL AS CHIEF OPERATING OFFICER
Interpace Biosciences Announces Reverse Stock Split to Support Proposed Nasdaq Uplisting
PARSIPPANY, NJ, Aug. 26, 2026 (GLOBE NEWSWIRE) — Interpace Biosciences, Inc. (OTCID: IDXG) (“Interpace” or the “Company”), an emerging leader in enabling personalized medicine, today announced that it will effect a 1-for-5 reverse stock split (“Reverse Stock Split”) of its issued and outstanding common stock. The Reverse Stock Split will become effective at 12:01 a.m. Eastern Time on August 27, 2026, and Interpace common stock is expected to begin trading on a split-adjusted basis on the OTCID quotation system (“OTCID”) as of the commencement of market open that same day. Interpace’s ticker symbol on the OTCID will temporarily change to IDXGD for a period of 20 trading days, including the effective date. The new CUSIP number for the common stock following the Reverse Stock Split will be 46062X402.
Seeking Greatness Reports More Than PLN 30 Million in Sales Over Four Years
Securities Class Action Trend Filings – August 2026 – JD Supra
Securities Class Action Trend Filings – August 2026 JD Supra
STEM Is Our Future – and Afterschool Programs Are Leading the Way
Washington, D.C., Aug. 26, 2026 (GLOBE NEWSWIRE) —
New Study Finds Huge Leap in Afterschool Programs Providing STEM Education,
Viking's $230M SPAC IPO lists on NYSE with Harneys as Cayman counsel – Dealroom
Viking has completed its initial public offering (IPO) as a Special Purpose Acquisition Company (SPAC), raising $230 million. The newly issued securities have begun trading…
Agents Are Choosing Carriers That Automate Submissions Say Findings in 2026 Insurance Agency-Carrier Connectivity Trends Survey Report
2026 Connectivity Report reveals submission automation, not commission, is now driving where agents place business
INDEPENDENT BOARD UPDATE ON OFFER
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION
JATT mastermind launches latest biotech-focused SPAC in $60M IPO – Fierce Biotech
JATT mastermind launches latest biotech-focused SPAC in $60M IPO Fierce Biotech
Uglybooks Expands Colored Paper Lineup with Launch of Uglysheets and Uglypads
New York paper goods brand introduces large-format colored art paper and curated multi-color sketching pads for working artists
Cofiroute successfully issued a 6.4-year €500 million bond
Nanterre, 26 August 2026
Cofiroute place avec succès une émission obligataire de 500 millions d’euros à 6,4 ans
Nanterre, le 26 août 2026
Manual.ly Launches a New Way to Solve Product Problems by Simply Uploading a Photo
Read manuals online for free, upload photos of product problems and get help from AI or real users in 164 languages
Multiple System Atrophy Clinical Trial Pipeline Gains Momentum: 22+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
The multiple system atrophy clinical trial analysis report delivers important insights into ongoing research of 24+ pipeline multiple system atrophy drugs, clinical strategies, upcoming therapeutics, and commercial analysis.
Connections Live 2026 Showcases How Modernized Platforms, Connected Workflows, and AI Are Reshaping Convenience Retail
Annual PDI Technologies conference highlighted innovations designed to help retailers, wholesalers, and brands improve productivity, accelerate decision making, and drive growth
RAMSAY SANTE : Résultats annuels provisoires à fin juin 2026
COMMUNIQUE DE PRESSE
FIELDBOSS Brings “Unfair Advantage” to NAEC 2026: A Half-Day Reckoning on AI for Elevator Contractors, Before the Show Floor Opens
CHICAGO, Aug. 26, 2026 (GLOBE NEWSWIRE) — 
Complimentary pre-day event in Chicago is nearing capacity as FIELDBOSS provides elevator contractor owners and back-office staff with real benchmark data and a governance framework for AI ahead of the industry’s largest annual gathering.
MERGE Acquires Brado’s Digital and Insight Practices to Deepen Behavioral Research and Accelerate AI-Driven Discoverability
Karman Line Acquisition Corp. Announces the Separate Trading of Its Class A Ordinary Shares and Warrants, Commencing on August 27, 2026
BOCA RATON, Fla., Aug. 26, 2026 (GLOBE NEWSWIRE) — Karman Line Acquisition Corp. (Nasdaq: XTERU) (the “Company”), a special purpose acquisition company, today announced that, commencing on August 27, 2026, holders of the units (the “Units”) sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares (the “Ordinary Shares”) and warrants (the “Warrants”) included in the Units.